The aim of the study is to assess the concentration of anti-inflammatory markers after the use of cervical spine mesotherapy in the course of pain syndrome. The study is randomized. Patients will be divided into two groups: A - mesotherapy using injectable type I collagen, B - mesotherapy using 1% lignocaine. The mesotherapy procedure will be performed five times, at weekly intervals. Blood will be collected before the start of mesotherapy, a week after its completion and after 3 months of follow-up. In addition, the effectiveness and safety of mesotherapy of the cervical spine will be assessed.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* patients with chronic (\>12 weeks) cervical spine pain syndrome of muscular, myofascial nature without radiation to the upper limb
* recent MRI or CT scan of the cervical spine (up to 6 months)
* no serious diseases: cancer, rheumatology, metabolic
* no allergy to lignocaine 1% or injectable type I collagen
Exclusion Criteria:
* another cause of cervical spine pain
* lack of patient consent
Primary outcome measure(s)
Concentration of anti-inflammatory markers — Blood collection before starting the mesotherapy treatment (on the same day), one week after its completion (after 5 weeks from start), and after 6 weeks from end Blood collection before starting the mesotherapy treatment (on the same day), one week after its completion, and after 6 weeks follow-up
Trial sites (1)
Facility
City
Region
Status
National Institute of Geriatric, Rheumatology and Rehabilitation
Warsaw
Poland
More National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland trials in Poland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.